Stanley-Laman Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-500
| Closed | -$242K | – | 260 |
|
|
2020
Q4 | $242K | Hold |
500
| – | – | 0.04% | 225 |
|
|
2020
Q3 | $280K | Buy |
+500
| New | +$280K | 0.06% | 208 |
|
|
2019
Q3 | – | Sell |
-757
| Closed | -$237K | – | 276 |
|
|
2019
Q2 | $237K | Buy |
+757
| New | +$237K | 0.06% | 254 |
|
|
2017
Q1 | – | Sell |
-2,977
| Closed | -$1.09M | – | 275 |
|
|
2016
Q4 | $1.09M | Buy |
2,977
+934
| +46% | +$343K | 0.34% | 109 |
|
|
2016
Q3 | $821K | Sell |
2,043
-39
| -2% | -$15.7K | 0.34% | 107 |
|
|
2016
Q2 | $727K | Buy |
+2,082
| New | +$727K | 0.28% | 136 |
|